Rossiello F, Aguado J, Sepe S, Iannelli F, Nguyen Q, Pitchiaya S, Carninci P, d'Adda di Fagagna F

Corrigendum: DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs.

Nat Commun 2017; 15344. doi: 10.1038/ncomms15344

Petrakis TG, Komseli ES, Papaioannou M, Vougas K, Polyzos A, Myrianthopoulos V, Mikros E, Trougakos IP, Thanos D, Branzei D, Townsend P, Gorgoulis VG

Erratum to 'Exploring and exploiting the systemic effects of deregulated replication licensing' [Seminars in Cancer Biology 37-38C, (2016) 3-15].

Semin Cancer Biol 2017; 180. doi: 10.1016/j.semcancer.2017.02.002

Frossi B, Tripodo C, Guarnotta C, Carroccio A, De Carli M, De Carli S, Marino M, Calabrò A, Pucillo CE

Mast cells are associated with the onset and progression of celiac disease.

J Allergy Clin Immunol 2017; 1266-1274.e1. doi: 10.1016/j.jaci.2016.08.011

Muñoz MJ, Nieto Moreno N, Giono LE, Cambindo Botto AE, Dujardin G, Bastianello G, Lavore S, Torres-Méndez A, Menck CFM, Blencowe BJ, Irimia M, Foiani M, Kornblihtt AR

Major Roles for Pyrimidine Dimers, Nucleotide Excision Repair, and ATR in the Alternative Splicing Response to UV Irradiation.

Cell Rep 2017; 2868-2879. doi: 10.1016/j.celrep.2017.02.066

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Oncogene 2017; 1200-1210. doi: 10.1038/onc.2016.283

Goyal L, Saha SK, Liu LY, Siravegna G, Leshchiner I, Ahronian LG, Lennerz JK, Vu P, Deshpande V, Kambadakone A, Mussolin B, Reyes S, Henderson L, Sun JE, Van Seventer EE, Gurski JM, Baltschukat S, Schacher-Engstler B, Barys L, Stamm C, Furet P, Ryan DP, Stone JR, Iafrate AJ, Getz G, Porta DG, Tiedt R, Bardelli A, Juric D, Corcoran RB, Bardeesy N, Zhu AX

Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

Cancer Discov 2017; 252-263. doi: 10.1158/2159-8290.CD-16-1000

Picco G, Petti C, Centonze A, Torchiaro E, Crisafulli G, Novara L, Acquaviva A, Bardelli A, Medico E

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.

EMBO Mol Med 2017; 293-303. doi: 10.15252/emmm.201606773

Heise C, Taha E, Murru L, Ponzoni L, Cattaneo A, Guarnieri FC, Montani C, Mossa A, Vezzoli E, Ippolito G, Zapata J, Barrera I, Ryazanov AG, Cook J, Poe M, Stephen MR, Kopanitsa M, Benfante R, Rusconi F, Braida D, Francolini M, Proud CG, Valtorta F, Passafaro M, Sala M, Bachi A, Verpelli C, Rosenblum K, Sala C

eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic Seizures.

Cereb Cortex 2017; 2226-2248. doi: 10.1093/cercor/bhw075

Grilli J, Osella M, Kennard AS, Lagomarsino MC

Relevant parameters in models of cell division control.

Phys Rev E 2017; 032411. doi: 10.1103/PhysRevE.95.032411

Zaccarin M, Bosello-Travain V, Di Paolo ML, Falda M, Maiorino M, Miotto G, Piccolo S, Roveri A, Ursini F, Venerando R, Toppo S

Redox status in a model of cancer stem cells.

Arch Biochem Biophys 2017; 120-128. doi: 10.1016/j.abb.2016.09.002

Pusceddu S, Verzoni E, Prinzi N, Mennitto A, Femia D, Grassi P, Concas L, Vernieri C, Lo Russo G, Procopio G

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.

Ther Adv Med Oncol 2017; 183-188. doi: 10.1177/1758834016683905

Rossiello F, Aguado J, Sepe S, Iannelli F, Nguyen Q, Pitchiaya S, Carninci P, d'Adda di Fagagna F

DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs.

Nat Commun 2017; 13980. doi: 10.1038/ncomms13980

Co AD, Lagomarsino MC, Caselle M, Osella M

Stochastic timing in gene expression for simple regulatory strategies.

Nucleic Acids Res 2017; 1069-1078. doi: 10.1093/nar/gkw1235

Torri A, Carpi D, Bulgheroni E, Crosti MC, Moro M, Gruarin P, Rossi RL, Rossetti G, Di Vizio D, Hoxha M, Bollati V, Gagliani C, Tacchetti C, Paroni M, Geginat J, Corti L, Venegoni L, Berti E, Pagani M, Matarese G, Abrignani S, de Candia P

Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity.

J Biol Chem 2017; 2903-2915. doi: 10.1074/jbc.M116.769893

Wlodarski M, Raciti B, Kotar J, Cosentino Lagomarsino M, Fraser GM, Cicuta P

Both genome and cytosol dynamics change in E. coli challenged with sublethal rifampicin.

Phys Biol 2017; 015005. doi: 10.1088/1478-3975/aa5b71

Picco G, Petti C, Sassi F, Grillone K, Migliardi G, Rossi T, Isella C, Di Nicolantonio F, Sarotto I, Sapino A, Bardelli A, Trusolino L, Bertotti A, Medico E

Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.

J Natl Cancer Inst 2017; . doi: 10.1093/jnci/djw209

Rustighi A, Zannini A, Campaner E, Ciani Y, Piazza S, Del Sal G

PIN1 in breast development and cancer: a clinical perspective.

Cell Death Differ 2017; 200-211. doi: 10.1038/cdd.2016.122

Myant KB, Cammareri P, Hodder MC, Wills J, Von Kriegsheim A, Győrffy B, Rashid M, Polo S, Maspero E, Vaughan L, Gurung B, Barry E, Malliri A, Camargo F, Adams DJ, Iavarone A, Lasorella A, Sansom OJ

HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.

EMBO Mol Med 2017; 181-197. doi: 10.15252/emmm.201606684

Jachetti E, Rigoni A, Bongiovanni L, Arioli I, Botti L, Parenza M, Cancila V, Chiodoni C, Festinese F, Bellone M, Tardanico R, Tripodo C, Colombo MP

Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β.

Mol Cancer Ther 2017; 365-375. doi: 10.1158/1535-7163.MCT-16-0466

Wanke F, Moos S, Croxford AL, Heinen AP, Gräf S, Kalt B, Tischner D, Zhang J, Christen I, Bruttger J, Yogev N, Tang Y, Zayoud M, Israel N, Karram K, Reißig S, Lacher SM, Reichhold C, Mufazalov IA, Ben-Nun A, Kuhlmann T, Wettschureck N, Sailer AW, Rajewsky K, Casola S, Waisman A, Kurschus FC

EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells.

Cell Rep 2017; 1270-1284. doi: 10.1016/j.celrep.2017.01.020

Sorrentino G, Ruggeri N, Zannini A, Ingallina E, Bertolio R, Marotta C, Neri C, Cappuzzello E, Forcato M, Rosato A, Mano M, Bicciato S, Del Sal G

Glucocorticoid receptor signalling activates YAP in breast cancer.

Nat Commun 2017; 14073. doi: 10.1038/ncomms14073

Sebesta M, Urulangodi M, Stefanovie B, Szakal B, Pacesa M, Lisby M, Branzei D, Krejci L

Esc2 promotes Mus81 complex-activity via its SUMO-like and DNA binding domains.

Nucleic Acids Res 2017; 215-230. doi: 10.1093/nar/gkw882

Sartore-Bianchi A, Pietrantonio F, Amatu A, Milione M, Cassingena A, Ghezzi S, Caporale M, Berenato R, Falcomatà C, Pellegrinelli A, Bardelli A, Nichelatti M, Tosi F, De Braud F, Di Nicolantonio F, Barault L, Siena S

Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients.

Eur J Cancer 2017; 43-50. doi: 10.1016/j.ejca.2016.10.032

Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R, Daniels MJ, Lu X, Tüting T, Middleton M, Buffa FM, Willis AE, Pavitt G, Ronai ZA, Sauka-Spengler T, Hölzel M, Goding CR

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.

Genes Dev 2017; 18-33. doi: 10.1101/gad.290940.116

Lo Sardo F, Forcato M, Sacconi A, Capaci V, Zanconato F, Di Agostino S, Del Sal G, Pandolfi PP, Strano S, Bicciato S, Blandino G

MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.

Carcinogenesis 2017; 64-75. doi: 10.1093/carcin/bgw110

Calamita P, Miluzio A, Russo A, Pesce E, Ricciardi S, Khanim F, Cheroni C, Alfieri R, Mancino M, Gorrini C, Rossetti G, Peluso I, Pagani M, Medina DL, Rommens J, Biffo S

SBDS-Deficient Cells Have an Altered Homeostatic Equilibrium due to Translational Inefficiency Which Explains their Reduced Fitness and Provides a Logical Framework for Intervention.

PLoS Genet 2017; e1006552. doi: 10.1371/journal.pgen.1006552

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Eye (Lond) 2017; 166. doi: 10.1038/eye.2016.276

Ruprecht V, Monzo P, Ravasio A, Yue Z, Makhija E, Strale PO, Gauthier N, Shivashankar GV, Studer V, Albiges-Rizo C, Viasnoff V

How cells respond to environmental cues - insights from bio-functionalized substrates.

J Cell Sci 2017; 51-61. doi: 10.1242/jcs.196162

Hayashi S, Morimoto M, Inomata H, Piccolo S

Size in development.

Dev Growth Differ 2017; 3. doi: 10.1111/dgd.12339

Siravegna G, Geuna E, Mussolin B, Crisafulli G, Bartolini A, Galizia D, Casorzo L, Sarotto I, Scaltriti M, Sapino A, Bardelli A, Montemurro F

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.

ESMO Open 2017; e000253. doi: 10.1136/esmoopen-2017-000253

Ibarra MS, Borini Etichetti C, Di Benedetto C, Rosano GL, Margarit E, Del Sal G, Mione M, Girardini J

Dynamic regulation of Pin1 expression and function during zebrafish development.

PLoS One 2017; e0175939. doi: 10.1371/journal.pone.0175939

Tosi A, Dalla Santa S, Cappuzzello E, Marotta C, Walerych D, Del Sal G, Zanovello P, Sommaggio R, Rosato A

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.

Oncoimmunology 2017; e1313371. doi: 10.1080/2162402X.2017.1313371

%PLACEHOLDER%